Cadrenal Therapeutics, Inc. (CVKD) Tops Q3 EPS by 8c

November 10, 2025 9:05 AM EST

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q3 EPS of ($1.31), $0.08 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK